when it ends, appetite returns (often stronger) The body defends against weight loss (an evolutionary survival mechanism) Lifestyle changes made while on medication may not be sustained without appetite suppression Metabolic rate decreases with weight loss, making it easy to regain if calorie intake increases Strategies to minimize regain (if you stop): Taper the dose gradually rather than stopping abruptly Transition to intensive behavioral support (counseling, nutrition coaching) Maintain calorie awareness and portion control habits developed on medication Prioritize protein intake and resistance exercise to preserve muscle mass Consider maintenance dose (lower dose to prevent regain, rather than full discontinuation) Accept that some regain is normal
Drugs alone are not enough, we must ensure access, education, and continuity to avoid widening inequalities
It is used as a fine, spherical, and porous powder in cosmetics
Some patients on higher doses may face additional cost variability
Die isolierte D-Ala2-Substitution senkte beim Menschen die metabolische Clearance von 39,7 auf 21 mL/kg/min und verlngerte die IV-Verschwinde-Halbwertszeit von 4,3 auf 6,7 Minuten (Soule 1994)
The existing law prohibits compounders from making "essentially" a copy of an existing commercially available drug